4.5 Article

Prognostic implications for high expression of oncogenic microRNAs in advanced gastric carcinoma

期刊

JOURNAL OF SURGICAL ONCOLOGY
卷 107, 期 5, 页码 505-510

出版社

WILEY
DOI: 10.1002/jso.23271

关键词

microRNA; advanced gastric carcinoma; prognosis

资金

  1. Korea Health Technology R&D Project, Ministry of Health & Welfare, Republic of Korea [A101140]
  2. Korea Health Promotion Institute [A101140] Funding Source: Korea Institute of Science & Technology Information (KISTI), National Science & Technology Information Service (NTIS)

向作者/读者索取更多资源

Background Aberrant expressions of specific microRNAs are recently known in many malignancies, including gastric carcinoma. The prognostic implication of oncogenic microRNA dysregulation was investigated in advanced gastric carcinomas undergoing radical resection and adjuvant systemic chemotherapy, and observed on long-term follow-up. Methods The expression levels of miR-20a, miR-21, miR-25, miR-93, miR-103, miR-106a, miR-106b, miR-130b, miR-155, miR-221, and miR-222 were analyzed in formalin-fixed paraffin-embedded (FFPE) cancer tissues of 91 patients, using reverse transcription real-time PCR. Results The high expression of miR-20a, miR-25, miR-93, miR-103, miR-106a, miR-106b, miR-130 was associated with lymph node metastasis (P<0.05), and high expression of miR-155 was related to tumor penetration through serosa and lymph node metastasis (P<0.05). Cases with high expression of miR-222 (P=0.014) showed reduced 5-year survival rates. The high expression of miR-222 and miR-221 showed correlation with shorter metastasis-free survival (P=0.039 and 0.033, respectively), and miR-222 high expression was related to reduced overall survival (P=0.012). Conclusions The high expression of miR-20a, miR-25, miR-93, miR-103, miR-106a, miR-106b, miR-130, miR-155, miR-221, and miR-222 in AGC tissues may be a high risk factor associated with tumor penetration through serosa, lymph node metastasis, distant metastasis, and poor long-term survival in patients undergoing radical resection and adjuvant systemic chemotherapy. J. Surg. Oncol. 2013;107:505510. (c) 2012 Wiley Periodicals, Inc.

作者

我是这篇论文的作者
点击您的名字以认领此论文并将其添加到您的个人资料中。

评论

主要评分

4.5
评分不足

次要评分

新颖性
-
重要性
-
科学严谨性
-
评价这篇论文

推荐

暂无数据
暂无数据